Artemis Medicare Services Ltd. AI Stock Analysis
Want to see IN:ARTEMISMED full AI Analyst Report?
Artemis Medicare Services Ltd. (ARTEMISMED) AI Stock Analysis
Artemis Medicare Services Ltd.
(NSE:ARTEMISMED)
The score is driven primarily by strong financial performance (growth, higher margins, and improved leverage) and supportive technical strength (clear uptrend with positive momentum). These positives are partially offset by weaker cash-flow consistency and a demanding valuation (high P/E), despite the supportive dividend yield.
Artemis Medicare Services Ltd. (ARTEMISMED) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 50.94B
- Dividend Yield
- 0.14%
- Average Volume (3M)
- 44.85K
- Price to Earnings (P/E)
- 43.3
- Beta (1Y)
- 0.82
- Revenue Growth
- 14.77%
- EPS Growth
- 8.40%
- Country
- India
- Employees
- 2,055
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Care Facilities
Artemis Medicare Services Ltd. Business Overview & Revenue Model
Company Description
Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, and inpatient and outpatient services. It also offers billing...
Artemis Medicare Services Ltd. Financial Statement Overview
Summary
Strong multi-year revenue growth and materially improved profitability through 2026 support a solid score. Balance sheet risk has eased with much lower debt-to-equity by 2026, but cash-flow quality is the main drag due to volatile free cash flow and weaker recent cash conversion.
Income Statement
78PositiveBalance Sheet
74PositiveCash Flow
58Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.50B | 10.81B | 9.37B | 8.79B | 7.37B | 5.53B |
| Gross Profit | 2.37B | 2.15B | 2.23B | 1.78B | 1.04B | 954.40M |
| EBITDA | 1.99B | 1.88B | 1.52B | 1.34B | 1.01B | 713.53M |
| Net Income | 1.15B | 1.04B | 826.26M | 491.41M | 385.98M | 318.14M |
Balance Sheet | ||||||
| Total Assets | 15.98B | 14.29B | 13.57B | 9.72B | 9.05B | 7.10B |
| Cash, Cash Equivalents and Short-Term Investments | 2.67B | 2.06B | 3.96B | 612.05M | 509.42M | 276.98M |
| Total Debt | 3.24B | 2.62B | 2.90B | 3.20B | 2.86B | 2.01B |
| Total Liabilities | 6.02B | 4.88B | 5.14B | 5.17B | 4.97B | 3.48B |
| Stockholders Equity | 9.89B | 9.35B | 8.38B | 4.48B | 4.03B | 3.59B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 321.88M | 524.65M | 363.01M | -337.68M | -573.20M |
| Operating Cash Flow | 0 | 1.37B | 1.46B | 1.09B | 1.13B | 515.80M |
| Investing Cash Flow | 0 | -1.19B | -3.85B | -891.04M | -1.58B | -1.08B |
| Financing Cash Flow | 0 | -265.64M | 2.67B | -41.48M | 521.82M | 528.37M |
Artemis Medicare Services Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ARTEMISMED, the sentiment is Positive. The current price of 321.25 is above the 20-day moving average (MA) of 300.46, above the 50-day MA of 320.03, and above the 200-day MA of 274.49, indicating a bullish trend. The MACD of -0.92 indicates Negative momentum. The RSI at 59.82 is Neutral, neither overbought nor oversold. The STOCH value of 89.67 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:ARTEMISMED.
Artemis Medicare Services Ltd. Peers Comparison
Overall Rating
IN:YATHARTH80Outperform
IN:KOVAI74Outperform
IN:JLHL72Outperform
IN:ARTEMISMED70Outperform
IN:RAINBOW61Neutral
IN:SHALBY35Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 80Outperform | INR 102.05B | 53.66 | ― | 0.05% | 50.40% | 24.94% | |
| 74Outperform | INR 71.39B | 26.55 | ― | 0.23% | 16.69% | 18.45% | |
| 72Outperform | INR 93.53B | 50.14 | ― | 0.07% | 16.71% | -6.09% | |
| 70Outperform | INR 50.18B | 43.25 | ― | 0.14% | 14.77% | 8.40% | |
| 61Neutral | INR 131.36B | 44.16 | ― | 0.27% | 22.83% | 15.15% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 35Underperform | INR 13.77B | 34.56 | ― | ― | 7.27% | 774.36% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:ARTEMISMED | Artemis Medicare Services Ltd. | 321.25 | 50.41 | 18.61% | |
| IN:JLHL | Jupiter Life Line Hospitals Ltd. | 283.50 | -7.07 | -2.43% | |
| IN:RAINBOW | Rainbow Childrens Medicare Limited | 1275.95 | -28.53 | -2.19% | |
| IN:SHALBY | Shalby Ltd. | 124.85 | -98.95 | -44.21% | |
| IN:YATHARTH | Yatharth Hospital and Trauma Care Services Limited | 1061.20 | 266.52 | 33.54% | |
| IN:KOVAI | Kovai Medical Center & Hospital Ltd. | 6570.25 | 515.27 | 8.51% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 26, 2026
